Abstract
Plants' reliance on molecular epigenetic control reflects their developmental, lifestyles, and the evolutionary histories. Plants grows by continually developing new parts from the self-sufficing stem cells population, termed as meristem, as opposed to mammals, whose tissues and organs formation is primarily determined during the embryo development. The interest in different medically active products has been developed to improve their pharmacokinetic and biological properties for utilizing glycosyl-conjugation. The conjugation of various drugs with various mono, di, or polysaccharides has boosted the therapeutic potentials of these drugs that is also manifested by a significant number of research papers. The current review article encapsulates extremely important and the up-to-date example of this conjugation, specially associated to enhancing antitumor activities of original glycoconjugates. The given examples along projected mechanisms of activities enhancement may guide to design, synthesize and evaluate new glycosyl conjugates for improved therapeutics.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
